International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 6 (November-December 2026) Submit your research before last 3 days of December to publish your research paper in the issue of November-December.

Shallaki (Boswellia serrata Roxb.) in the Management of Primary Dysmenorrhea: Bridging Ayurvedic Concepts and Contemporary Pharmacological Evidence

Author(s) Dr. Ramila Bhinde, Vd Grishma Solanki
Country India
Abstract Background: Primary dysmenorrhea is a common gynaecological disorder characterized by painful menstruation in the absence of pelvic pathology, significantly affecting the quality of life of women, particularly adolescents and young adults. Although NSAIDs and hormonal therapies are effective for many women, treatment choice should consider individual contraindications, tolerability, and the possibility of recurrence after discontinuation. Ayurveda correlates primary dysmenorrhea with Kashtartava, predominantly resulting from the vitiation of Apana Vata. Shallaki (Boswellia serrata Roxb.), a renowned Ayurvedic medicinal plant, has been traditionally used for inflammatory and painful disorders and has gained increasing scientific attention because of its diverse pharmacological properties. Objective: This review aims to critically examine the therapeutic potential of Shallaki in the management of primary dysmenorrhea by integrating classical Ayurvedic concepts with contemporary pharmacological evidence. Methods: A narrative review was conducted using classical Ayurvedic texts and published scientific literature. Evidence related to the phytochemistry, pharmacological actions, molecular mechanisms, and potential role of Boswellia serrata in primary dysmenorrhea was critically synthesized. Results: Boswellic acids, particularly AKBA, have demonstrated anti-inflammatory and other pharmacological activities in preclinical and clinical studies, including modulation of 5-lipoxygenase and inflammatory signalling pathways through inhibition of the 5-lipoxygenase pathway, modulation of inflammatory cytokines, suppression of NF-κB signaling, and reduction of oxidative stress. These pharmacological findings may be conceptually correlated with the Ayurvedic properties attributed to Shallaki, including Shothahara and Vedanasthapana. The available evidence provides a plausible mechanistic basis for the potential role of Shallaki in reducing uterine inflammation, hypercontractility, ischemia, and menstrual pain. However, direct clinical evidence in women with primary dysmenorrhea remains limited. Conclusion: The integration of Ayurvedic principles with contemporary pharmacological evidence suggests that Shallaki may serve as a promising complementary therapeutic option for primary dysmenorrhea. Nevertheless, well-designed randomized controlled trials employing standardized formulations are required to establish its clinical efficacy, optimal dosage, and long-term safety.
Keywords Primary dysmenorrhea; Kashtartava; Boswellia serrata; Shallaki; Boswellic acids; Ayurveda; Inflammation; Integrative medicine
Field Medical / Pharmacy
Published In Volume 8, Issue 6, November-December 2026
Published On 2026-11-05

Share this